The pharmaceutical industry has overcome the challenges that have been presented. We are currently at a time when we must face great challenges: regulatory changes, automation of production and control processes; technological changes, such as the implementation of industry 4.0; scientific changes, such as the strong development of biotechnological products, and the great change that the COVID-19 coronavirus pandemic is representing at all levels.
Process automation systems and the introduction of sensors, actuators and general instrumentation have been crucial for the pharmaceutical industry. Process automation systems and the introduction of sensors, actuators and general instrumentation have been crucial for the pharmaceutical industry. The great challenge for the industry is to produce the medicines in a profitable and effective way, but also, and not less important, to maintain a high degree of quality and safety in the products.
Another challenge we face in the pharmaceutical industry, in terms of innovation and technological development, is the application of industry 4.0 technology. This set of technologies advances in an unstoppable way. Industry 4.0 implies the incorporation of data management techniques into industrial processes, taking advantage of the developments that are being carried out in other areas in the field of Big Data. The objective of these techniques is the optimization of the processes and this implies economic benefits and important improvements in the quality and safety of the medicines. We are, without a doubt, facing a great opportunity and challenge in our industry. It is important to take advantage of the impulse that technology provides us to implement improvements.